Brinker Capital Investments’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Brinker Capital Investments's HALO Position: Q2 2026 in Review
Brinker Capital Investments reduced its Halozyme (HALO) stake by 5.7% in Q2 2026, selling an estimated $84.1K and leaving 20,471 shares worth $1.6M. The position accounts for 0.01% of the portfolio, ranked #920.
Brinker Capital Investments first reported a position in HALO in Q4 2019 and has held it in 22 quarters since. The position peaked at $1.98M in Q4 2022. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Brinker Capital Investments held 20,471 shares of Halozyme worth $1.6M as of Q2 2026.
- Brinker Capital Investments sold 1,234 Halozyme shares in Q2 2026, an estimated $84.1K.
- Halozyme made up 0.01% of Brinker Capital Investments's portfolio in Q2 2026, its #920 holding.
- Brinker Capital Investments first reported a position in Halozyme in Q4 2019 and has held it in 22 quarters since.
- Brinker Capital Investments's Halozyme position peaked at $1.98M in Q4 2022.
- 674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Brinker Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.